김태혁 교수
#갑상선질환#갑상선암
|
학력
2016.02 서울대학교 의과대학 대학원 의학과 졸업(박사)
2010.02 서울대학교 의과대학 대학원 의학과 졸업(석사)
2005.02 서울대학교 의과대학 의학과 졸업(의학사)
2010.02 서울대학교 의과대학 대학원 의학과 졸업(석사)
2005.02 서울대학교 의과대학 의학과 졸업(의학사)
경력
2019.03 ~현재 성균관의대 삼성서울병원 내과 조교수
2018.03 ~ 2019.02 삼성서울병원 내분비-대사 내과 전임대우조교수
2015.03 ~ 2018.02 삼성서울병원 내분비-대사 내과 임상전임강사
2015.10 내분비-대사 내과 분과전문의 자격 취득
2014.03 ~ 2015.02 서울대학교병원 내분비-대사 내과 진료조교수
2013.05 ~ 2014.02 서울대학교병원 내분비-대사 내과 전임의
2011.05 ~ 2013.04 국군대전병원 내과 군의관
2010.05 ~ 2011.04 22사단신교대대 의무실장
2010.03 내과 전문의 자격 취득
2006.03 ~ 2010.02 서울대학교병원 내과 레지던트
2005.03 ~ 2006.02 서울대학교병원 인턴 수료
2018.03 ~ 2019.02 삼성서울병원 내분비-대사 내과 전임대우조교수
2015.03 ~ 2018.02 삼성서울병원 내분비-대사 내과 임상전임강사
2015.10 내분비-대사 내과 분과전문의 자격 취득
2014.03 ~ 2015.02 서울대학교병원 내분비-대사 내과 진료조교수
2013.05 ~ 2014.02 서울대학교병원 내분비-대사 내과 전임의
2011.05 ~ 2013.04 국군대전병원 내과 군의관
2010.05 ~ 2011.04 22사단신교대대 의무실장
2010.03 내과 전문의 자격 취득
2006.03 ~ 2010.02 서울대학교병원 내과 레지던트
2005.03 ~ 2006.02 서울대학교병원 인턴 수료
논문
NUCL MED COMMUN 2020 10.1097/MNM.0000000000001138
The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study
Park1, H; Kim, HI; Park, J; Park, SY; Kim, TH; Chung, JH; Choi, JY; Kim, SW
CANCERS 2020 10.3390/cancers12030625
Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer
Kim1, H; Park, SY; Choe, JH; Kim, JS; Hahn, SY; Kim, SW; Chung, JH; Jung, J; Kim, TH
CLIN ENDOCRINOL 2020 10.1111/cen.14167
Ultrasound-guided fine-needle aspiration or core needle biopsy for diagnosing follicular thyroid carcinoma?
Park1, KW; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Kim, TH; Chung, JH
ACTA RADIOL 2020 10.1177/0284185119847677
Comparison of ultrasonography and CT for preoperative nodal assessment of patients with papillary thyroid cancer: diagnostic performance according to primary tumor size
Yang1, SY; Shin, JH; Hahn, SY; Lim, Y; Hwang, SY; Kim, TH; Kim, JS
SCI REP-UK 2019 10.1038/s41598-019-55370-w
Improved survival after early detection of asymptomatic distant metastasis in patients with thyroid cancer
Kim1, H; Park, SY; Jung, J; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Chung, MK; Kim, HI; Kim, SW; Chung, JH; Kim, TH
THYROID 2019 10.1089/thy.2019.0261
Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis
Park1, J; Kim, JW; Park, H; Park, SY; Kim, TH; Kim, SW; Oh, YL; Chung, JH
EUR J NUTR 2019 10.1007/s00394-018-1837-4
Non-immune-related hypothyroidism and its relationship with excess iodine
Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Han, JM; Bae, JC; Kim, SW; Kim, TH; Chung, JH
THYROID 2019 10.1089/thy.2019.0246
Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study
Oh1, HS; Shin, DY; Kim, M; Park, SY; Kim, TH; Kim, BH; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Lim, DJ; Kim, WG
THYROID 2019 10.1089/thy.2018.0541
Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma
Kim1, HI; Hyeon, J; Park, SY; Ahn, HS; Kim, K; Han, JM; Bae, JC; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH; Oh, YL
ENDOCRINE 2019 10.1007/s12020-018-1807-x
Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin
Cho1, YY; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Chung, JH; Kim, SW
EUR J NUTR 2019 10.1007/s00394-017-1587-8
Urinary iodine concentration and thyroid hormones: Korea National Health and Nutrition Examination Survey 2013-2015
Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Kim, SW; Kim, TH; Chung, JH
ORAL ONCOL 2019 10.1016/j.oraloncology.2018.12.014
Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma
Kim1, YN; Kim, M; Ahn, HS; Kim, K; Park, SY; Kim, HI; Jeon, MJ; Kim, WG; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, TY; Kim, TH
THYROID 2018 10.1089/thy.2018.0263
Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea
Oh1, HS; Ha, J; Kim, HI; Kim, TH; Kim, WG; Lim, DJ; Kim, TY; Kim, SW; Kim, WB; Shong, YK; Chung, JH; Baek, JH
J CLIN ENDOCR METAB 2018 10.1210/jc.2018-01386
Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma
Park1, SY; Cho, YY; Kim, HI; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Kim, SW; Chung, JH; Kim, TH
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.10.029
Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study
Kim1, M; Kim, HI; Jeon, MJ; Kim, HK; Kim, EH; Yi, HS; Kim, ES; Kim, H; Kim, BH; Kim, TY; Kim, SW; Kang, HC; Kim, WB; Chung, JH; Shong, YK; Kim, TH; Kim, WG
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.09.008
Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study
Kim1, M; Kim, HK; Kim, HI; Kim, EH; Jeon, MJ; Yi, HS; Kim, ES; Kim, H; Kim, TH; Kim, BH; Kim, TY; Kang, HC; Kim, WB; Chung, JH; Shon, YK; Kim, SW; Kim, WG
SCI REP-UK 2018 10.1038/s41598-018-31955-9
Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance
Lee1, YB; Kim, JY; Cho, H; Hahn, SY; Shin, JH; Lee, SE; Jun, JE; Kim, SW; Chung, JH; Kim, TH; Oh, YL
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.07.002
Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles
Park1, SY; Kim, HI; Choi, JY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, SH; Kim, K; Jeong, JG; Kim, SW; Chung, JH; Kim, TH
BRIT J SURG 2018 10.1002/bjs.10830
Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma
Park1, SY; Kim, HI; Kim, JH; Kim, JS; Oh, YL; Kim, SW; Chung, JH; Jang, HW; Kim, TH
THYROID 2018 10.1089/thy.2017.0550
Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea
Cho1, YY; Kang, MJ; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Nam, JY; Lee, BW; Lee, YH; Chung, JH; Song, SO; Kim, SW
KOREAN JOURNAL OF INTERNAL MEDICINE 2018 10.3904/kjirn.2016.051
Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area
Kim1, HJ; Cho, YY; Kim, SW; Kim, TH; Jang, HW; Lee, SY; Choi, SJ; Roh, CR; Kim, JH; Chung, JH; Oh, SY
THYROID 2018 10.1089/thy.2017.0356
Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study
Kim1, M; Kim, TH; Shin, DY; Lim, DJ; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Kim, BH; Kim, WG
THYROID 2018 10.1089/thy.2017.0356
Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study
Kim1, M; Kim, TH; Shin, DY; Lim, DJ; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Kim, BH; Kim, WG
HISTOPATHOLOGY 2018 10.1111/his.13401
Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma
Kim1, TH; Lee, M; Kwon, AY; Choe, JH; Kim, JH; Kim, JS; Hahn, SY; Shin, JH; Chung, MK; Son, YI; Ki, CS; Yim, HS; Kim, YL; Chung, JH; Kim, SW; Oh, YL
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.01.021
Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis
Kim1, HI; Kim, K; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, HS; Kim, SW; Kim, TH; Chung, JH
ANN INTERN MED 2018 10.7326/M17-1398
Antithyroid Drugs and Congenital Malformations A Nationwide Korean Cohort Study
Seo1, GH; Kim, TH; Chung, JH
J CLIN ENDOCR METAB 2018 10.1210/jc.2017-01775
High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance
Kim1, HI; Jang, HW; Ahn, HS; Ahn, S; Park, SY; Oh, YL; Hahn, SY; Shin, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW
PLoS One 2018 10.1371/journal.pone.0190738
Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015)
Park1, SY; Kim, HI; Oh, HK; Kim, TH; Jang, HW; Chung, JH; Shin, MH; Kim, SW
CLIN ENDOCRINOL 2018 10.1111/cen.13489
Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up
Sohn1, SY; Kim, HI; Kim, YN; Kim, TH; Kim, W; Chung, JH
BRIT J SURG 2018 10.1002/bjs.10655
Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis
Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Kim, YN; Kim, H; Kim, SW; Chung, JH
외 다수
The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study
Park1, H; Kim, HI; Park, J; Park, SY; Kim, TH; Chung, JH; Choi, JY; Kim, SW
CANCERS 2020 10.3390/cancers12030625
Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer
Kim1, H; Park, SY; Choe, JH; Kim, JS; Hahn, SY; Kim, SW; Chung, JH; Jung, J; Kim, TH
CLIN ENDOCRINOL 2020 10.1111/cen.14167
Ultrasound-guided fine-needle aspiration or core needle biopsy for diagnosing follicular thyroid carcinoma?
Park1, KW; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Kim, TH; Chung, JH
ACTA RADIOL 2020 10.1177/0284185119847677
Comparison of ultrasonography and CT for preoperative nodal assessment of patients with papillary thyroid cancer: diagnostic performance according to primary tumor size
Yang1, SY; Shin, JH; Hahn, SY; Lim, Y; Hwang, SY; Kim, TH; Kim, JS
SCI REP-UK 2019 10.1038/s41598-019-55370-w
Improved survival after early detection of asymptomatic distant metastasis in patients with thyroid cancer
Kim1, H; Park, SY; Jung, J; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Chung, MK; Kim, HI; Kim, SW; Chung, JH; Kim, TH
THYROID 2019 10.1089/thy.2019.0261
Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis
Park1, J; Kim, JW; Park, H; Park, SY; Kim, TH; Kim, SW; Oh, YL; Chung, JH
EUR J NUTR 2019 10.1007/s00394-018-1837-4
Non-immune-related hypothyroidism and its relationship with excess iodine
Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Han, JM; Bae, JC; Kim, SW; Kim, TH; Chung, JH
THYROID 2019 10.1089/thy.2019.0246
Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study
Oh1, HS; Shin, DY; Kim, M; Park, SY; Kim, TH; Kim, BH; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Lim, DJ; Kim, WG
THYROID 2019 10.1089/thy.2018.0541
Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma
Kim1, HI; Hyeon, J; Park, SY; Ahn, HS; Kim, K; Han, JM; Bae, JC; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH; Oh, YL
ENDOCRINE 2019 10.1007/s12020-018-1807-x
Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin
Cho1, YY; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Chung, JH; Kim, SW
EUR J NUTR 2019 10.1007/s00394-017-1587-8
Urinary iodine concentration and thyroid hormones: Korea National Health and Nutrition Examination Survey 2013-2015
Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Kim, SW; Kim, TH; Chung, JH
ORAL ONCOL 2019 10.1016/j.oraloncology.2018.12.014
Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma
Kim1, YN; Kim, M; Ahn, HS; Kim, K; Park, SY; Kim, HI; Jeon, MJ; Kim, WG; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, TY; Kim, TH
THYROID 2018 10.1089/thy.2018.0263
Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea
Oh1, HS; Ha, J; Kim, HI; Kim, TH; Kim, WG; Lim, DJ; Kim, TY; Kim, SW; Kim, WB; Shong, YK; Chung, JH; Baek, JH
J CLIN ENDOCR METAB 2018 10.1210/jc.2018-01386
Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma
Park1, SY; Cho, YY; Kim, HI; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Kim, SW; Chung, JH; Kim, TH
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.10.029
Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study
Kim1, M; Kim, HI; Jeon, MJ; Kim, HK; Kim, EH; Yi, HS; Kim, ES; Kim, H; Kim, BH; Kim, TY; Kim, SW; Kang, HC; Kim, WB; Chung, JH; Shong, YK; Kim, TH; Kim, WG
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.09.008
Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study
Kim1, M; Kim, HK; Kim, HI; Kim, EH; Jeon, MJ; Yi, HS; Kim, ES; Kim, H; Kim, TH; Kim, BH; Kim, TY; Kang, HC; Kim, WB; Chung, JH; Shon, YK; Kim, SW; Kim, WG
SCI REP-UK 2018 10.1038/s41598-018-31955-9
Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance
Lee1, YB; Kim, JY; Cho, H; Hahn, SY; Shin, JH; Lee, SE; Jun, JE; Kim, SW; Chung, JH; Kim, TH; Oh, YL
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.07.002
Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles
Park1, SY; Kim, HI; Choi, JY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, SH; Kim, K; Jeong, JG; Kim, SW; Chung, JH; Kim, TH
BRIT J SURG 2018 10.1002/bjs.10830
Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma
Park1, SY; Kim, HI; Kim, JH; Kim, JS; Oh, YL; Kim, SW; Chung, JH; Jang, HW; Kim, TH
THYROID 2018 10.1089/thy.2017.0550
Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea
Cho1, YY; Kang, MJ; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Nam, JY; Lee, BW; Lee, YH; Chung, JH; Song, SO; Kim, SW
KOREAN JOURNAL OF INTERNAL MEDICINE 2018 10.3904/kjirn.2016.051
Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area
Kim1, HJ; Cho, YY; Kim, SW; Kim, TH; Jang, HW; Lee, SY; Choi, SJ; Roh, CR; Kim, JH; Chung, JH; Oh, SY
THYROID 2018 10.1089/thy.2017.0356
Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study
Kim1, M; Kim, TH; Shin, DY; Lim, DJ; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Kim, BH; Kim, WG
THYROID 2018 10.1089/thy.2017.0356
Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study
Kim1, M; Kim, TH; Shin, DY; Lim, DJ; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Kim, BH; Kim, WG
HISTOPATHOLOGY 2018 10.1111/his.13401
Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma
Kim1, TH; Lee, M; Kwon, AY; Choe, JH; Kim, JH; Kim, JS; Hahn, SY; Shin, JH; Chung, MK; Son, YI; Ki, CS; Yim, HS; Kim, YL; Chung, JH; Kim, SW; Oh, YL
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.01.021
Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis
Kim1, HI; Kim, K; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, HS; Kim, SW; Kim, TH; Chung, JH
ANN INTERN MED 2018 10.7326/M17-1398
Antithyroid Drugs and Congenital Malformations A Nationwide Korean Cohort Study
Seo1, GH; Kim, TH; Chung, JH
J CLIN ENDOCR METAB 2018 10.1210/jc.2017-01775
High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance
Kim1, HI; Jang, HW; Ahn, HS; Ahn, S; Park, SY; Oh, YL; Hahn, SY; Shin, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW
PLoS One 2018 10.1371/journal.pone.0190738
Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015)
Park1, SY; Kim, HI; Oh, HK; Kim, TH; Jang, HW; Chung, JH; Shin, MH; Kim, SW
CLIN ENDOCRINOL 2018 10.1111/cen.13489
Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up
Sohn1, SY; Kim, HI; Kim, YN; Kim, TH; Kim, W; Chung, JH
BRIT J SURG 2018 10.1002/bjs.10655
Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis
Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Kim, YN; Kim, H; Kim, SW; Chung, JH
외 다수
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.